Pharma Bio OTC Stock Insiders

PBSV Stock  USD 0.55  0.06  9.84%   
Pharma Bio employs about 140 people. The company is managed by 4 executives with a total tenure of roughly 28 years, averaging almost 7.0 years of service per executive, having 35.0 employees per reported executive. Recap of Pharma Bio's management performance can provide insight into the venture performance.
Victor Sanchez  CEO
CEO and President and President of European Operations
Elizabeth Plaza  Chairman
Founder, Chairman, Sr. Strategic Consultant and Member of Nominating Committee
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pharma Bio Serv. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in state.

Pharma Bio Management Team Effectiveness

The company has return on total asset (ROA) of 0.033 % which means that it generated a profit of $0.033 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0568 %, meaning that it created $0.0568 on every $100 dollars invested by stockholders. Pharma Bio's management efficiency ratios could be used to measure how well Pharma Bio manages its routine affairs as well as how well it operates its assets and liabilities.

Pharma Bio Workforce Comparison

Pharma Bio Serv is considered to be number one stock in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 237. Pharma Bio totals roughly 140 in number of employees claiming about 59% of equities under Health Care industry.
The company has Profit Margin (PM) of 0.05 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.06 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.06.

Pharma Bio Serv Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Pharma Bio Serv Price Series Summation is a cross summation of Pharma Bio price series and its benchmark/peer.

Pharma Bio Notable Stakeholders

A Pharma Bio stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Pharma Bio often face trade-offs trying to please all of them. Pharma Bio's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Pharma Bio's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Victor SanchezCEO and President and President of European OperationsProfile
Elizabeth PlazaFounder, Chairman, Sr. Strategic Consultant and Member of Nominating CommitteeProfile
Pedro LasantaCFO, VP of Fin. and Admin. and SecretaryProfile
Miriam MBAHR MangProfile

About Pharma Bio Management Performance

The success or failure of an entity such as Pharma Bio Serv often depends on how effective the management is. Pharma Bio management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Pharma management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Pharma management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Pharma-Bio Serv, Inc. operates as a compliance and technology transfer services consulting firm. The company was founded in 1993 and is headquartered in Dorado, Puerto Rico. Pharma Bio operates under Health Information Services classification in the United States and is traded on OTC Exchange. It employs 190 people.
The data published in Pharma Bio's official financial statements typically reflect Pharma Bio's business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving Pharma Bio's quantitative information. For example, before you start analyzing numbers published by Pharma accountants, it's essential to understand Pharma Bio's liquidity, profitability, and earnings quality within the context of the Life Sciences Tools & Services space in which it operates.
Please note, the imprecision that can be found in Pharma Bio's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Pharma Bio Serv. Check Pharma Bio's Beneish M Score to see the likelihood of Pharma Bio's management manipulating its earnings.

Pharma Bio Workforce Analysis

Traditionally, organizations such as Pharma Bio use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Pharma Bio within its industry.

Pharma Bio Manpower Efficiency

Return on Pharma Bio Manpower

Revenue Per Employee138.6K
Revenue Per Executive4.8M
Net Income Per Employee7.2K
Net Income Per Executive251.7K
Working Capital Per Employee147.2K
Working Capital Per Executive5.2M

Additional Tools for Pharma OTC Stock Analysis

When running Pharma Bio's price analysis, check to measure Pharma Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharma Bio is operating at the current time. Most of Pharma Bio's value examination focuses on studying past and present price action to predict the probability of Pharma Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharma Bio's price. Additionally, you may evaluate how the addition of Pharma Bio to your portfolios can decrease your overall portfolio volatility.